Xiaoqing Yang

Also affiliated with Tianjin University, Nantong University, Wenzhou Medical University, Affiliated Hospital of Nantong University, Ruian People's Hospital, ZheJiang Academy of Agricultural Sciences, Anhui Institute of Information Technology, Shandong Provincial QianFoShan Hospital, The First People's Hospital of Xiaoshan District, Hangzhou, Institute of New Materials, Children’s Hospital of Fudan University Xiamen Branch, Shandong First Medical University, Hebei GEO University

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial”.

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30525-8

N/A

5.3DataRank · unranked

407 citations

Simon J. Harrison, Michèle Cavo, Javier de la Rubia, Rakesh Popat, Cristina Gasparetto +15 more

Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells

Scientific Reports(2021)10.1038/s41598-020-79524-3

N/A

0DataRank · unranked

40 citations

Yifan Zhang, Wangli Zhang, Xin Chen, Tong Xu, Sheng Hu +5 more